Special Edition
 Life Science Nation Newsletter  | August 30, 2018   |  Issue 281

 Life Science
Investor Mandates
(Aug. 23 - Aug. 29 )

By Nono Hu, Director of Marketing, LSN

In just a week's time, Life Science Nation will be bringing the Redefining Early Stage Investments (RESI) Conference back to the Marriott Copley Place in downtown Boston. Over 700 attendees from the early stage life science world will be at RESI, including startups at the earliest stages of development representing tech hubs from all around the US Northeast in the new RESI Innovator's Gathering, plus over 300 investors. You can read the program guide below to plan out your day at RESI and see who else will be there. We look forward to seeing you next week.

Created & Produced by
 Life Science
Investor Mandates
(Aug. 23 - Aug. 29 )
Invests in Global Therapeutics and Medical Device Technologies that Address Unmet Medical Needs
with Expanded Interests in Healthcare Seeks to Invest in Healthcare Solutions that Leverage Data and Technology
Invests Up to $10M in Therapeutics and Diagnostics Companies with a Strong China Angle
Allocates Up to $10M in Therapeutics, Medical Device, Diagnostics, and Digital Health Innovations
Invests in Medical Device, Diagnostic, and Digital Health Companies in USA and China
Seeks Novel Therapeutic Candidates Across CNS, Oncology, Liver Disease, and Other Indications Globally
Invests in Novel Therapeutics, Devices, Diagnostics & Life Science Tools
with $300M Fund Invests in North American Life Science Technologies with Strong China Market Potential, with Particular Interest in Vaccines
with $2B RMB AUM Seeks to Invest in Therapeutics and Medical Device Companies with Strong Clinical Efficacy Data
Invests in Global Digital Health Solutions for Chronic Diseases, Consumer & Mental Health, and Other Indications
Life Science Nation Media Partner